mRNA COVID-19 Vaccines Greatly Reduce Risk of Asymptomatic COVID-19 Infection

Ten days after receiving a second dose of a messenger RNA, or mRNA, vaccine for COVID-19, patients without COVID-19 symptoms are far less likely to test positive and unknowingly spread COVID-19, compared to patients who have not been vaccinated for COVID-19. The Pfizer-BioNTech and Moderna messenger RNA vaccines for COVID-19 are authorized for emergency use in the U.S.

With two doses of a messenger RNA COVID-19 vaccine, people with no symptoms showed an 80% lower adjusted risk of testing positive for COVID-19 after their last dose. Those are the findings of a Mayo Clinic study of vaccinated patients. These finding appear in the journal Clinical Infectious Diseases.

The authors say these findings underscore the efficacy of messenger RNA vaccines for COVID-19 to significantly limit the spread of COVID-19 by people with no symptoms who may unknowingly spread the infection to others.

The researchers retrospectively looked at a cohort of 39,000 patients who underwent pre-procedural molecular screening tests for COVID-19. More than 48,000 screening tests were performed, including 3,000 screening tests on patients who had received at least one dose of a messenger RNA COVID-19 vaccine. These screening tests were part of routine COVID-19 testing prior to treatments not related to COVID-19, such as surgeries and other procedures. Patients in the vaccinated group had received at least one dose of a messenger RNA COVID-19 vaccine.

"We found that those patients without symptoms receiving at least one dose of the first authorized mRNA COVID-19 vaccine, Pfizer-BioNTech, 10 days or more prior to screening were 72% less likely to test positive," says Aaron Tande, MD, a Mayo Clinic infectious diseases specialist and co-first author of the paper. "Those receiving two doses were 73% less likely, compared to the unvaccinated group."

After adjusting for a range of factors, researchers found an 80% risk reduction of testing positive for COVID-19 among those with two doses of a messenger RNA COVID-19 vaccine.

The study was based on patients receiving screening tests between Dec. 17, 2020, and Feb. 8 at Mayo Clinic in Minnesota and Arizona and at Mayo Clinic Health System in Minnesota and Wisconsin.

Source: Mayo Clinic

5 Comments on "mRNA COVID-19 Vaccines Greatly Reduce Risk of Asymptomatic COVID-19 Infection"

  1. 141265 810207Aw, i thought this was an incredibly great post. In idea I would like to invest writing in this way moreover – taking time and actual effort to manufacture a really good article but exactly what do I say I procrastinate alot and no indicates apparently go completed. 409234

  2. 605931 618117Ill proper away grasp your rss feed as I cant in obtaining your email subscription hyperlink or e-newsletter service. Do youve any? Please let me comprehend so that I might subscribe. Thanks. 327650

  3. 479609 539931Paris Hilton: So lovely spending time with Manny and h 129852

  4. 998813 477930Hi this is somewhat of off topic but I was wondering if blogs use WYSIWYG editors or in case you have to manually code with HTML. Im starting a weblog soon but have no coding expertise so I wanted to get guidance from someone with experience. Any help would be greatly appreciated! 100940

  5. 361549 937951Speedily and easily build your internet traffic and PR, which provides Internet internet site visitors to add your page to any social bookmarking web site. 609569

Leave a comment

Your email address will not be published.


*